Objectives:

1. Discus the background, methods and results of the randomized, double-blind trial of canakinumab.

 

Session date: 
08/10/2018 - 7:30am to 8:30am CDT
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Omer Iftikhar, MD